PulseAugur
EN
LIVE 19:49:57

Montana's 'right to try' law offers hope for experimental drug access

By PulseAugur Editorial · [1 sources] ·

Montana has enacted a new "right to try" law that aims to provide terminally ill patients with access to experimental drugs not yet approved by the FDA. One such patient, Kris DeVault, is seeking access to an experimental drug for his son Brody, who suffers from creatine transporter deficiency. While the drug shows promise in animal and early human trials, it is not yet approved and faces regulatory hurdles for broader access in the US, leaving DeVault concerned about his son's limited developmental window. AI

RANK_REASON The cluster discusses a new state law impacting access to experimental treatments, which is a significant policy development. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on MIT Technology Review →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Montana's 'right to try' law offers hope for experimental drug access

COVERAGE [1]

  1. MIT Technology Review TIER_1 English(EN) · Jessica Hamzelou ·

    Montana’s new “right to try” law can’t come soon enough for some

    Kris DeVault is desperate. His son, Brody, was born in March 2023. It wasn’t long before he started to show signs of developmental delay, says DeVault. As time went on, Brody started missing key milestones in speech, movement, and coordination, he says. When Brody was around two …

RELATED ENTITIES

RELATED TOPICS